Millennium Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.2M | Sell |
832,600
-428,700
| -34% | -$34.3M | 0.02% | 801 |
|
|
2025
Q4 | $120M | Buy |
1,261,300
+878,300
| +229% | +$86.1M | 0.05% | 363 |
|
|
2025
Q3 | $37.4M | Buy |
383,000
+83,700
| +28% | +$8.67M | 0.02% | 1080 |
|
|
2025
Q2 | $32.1M | Buy |
299,300
+139,100
| +87% | +$14.1M | 0.02% | 1130 |
|
|
2025
Q1 | $16.2M | Buy |
160,200
+29,600
| +23% | +$2.98M | 0.01% | 1732 |
|
|
2024
Q4 | $11.7M | Sell |
130,600
-69,100
| -35% | -$6.08M | 0.01% | 2032 |
|
|
2024
Q3 | $16.7M | Sell |
199,700
-96,500
| -33% | -$7.61M | 0.01% | 1718 |
|
|
2024
Q2 | $22.8M | Sell |
296,200
-142,800
| -33% | -$10.5M | 0.01% | 1379 |
|
|
2024
Q1 | $30.1M | Sell |
439,000
-378,400
| -46% | -$24.3M | 0.01% | 1194 |
|
|
2023
Q4 | $47.3M | Sell |
817,400
-42,100
| -5% | -$2.25M | 0.02% | 839 |
|
|
2023
Q3 | $45.4M | Buy |
859,500
+423,900
| +97% | +$22.2M | 0.02% | 771 |
|
|
2023
Q2 | $23.6M | Sell |
435,600
-119,700
| -22% | -$6.25M | 0.01% | 1261 |
|
|
2023
Q1 | $27.8M | Buy |
555,300
+151,200
| +37% | +$7.13M | 0.02% | 1088 |
|
|
2022
Q4 | $18.7M | Buy |
404,100
+60,900
| +18% | +$2.64M | 0.01% | 1510 |
|
|
2022
Q3 | $13.3M | Buy |
343,200
+13,200
| +4% | +$530K | 0.01% | 1801 |
|
|
2022
Q2 | $12.3M | Sell |
330,000
-500,000
| -60% | -$20.4M | 0.01% | 1789 |
|
|
2022
Q1 | $36.8M | Buy |
830,000
+635,100
| +326% | +$27.5M | 0.02% | 889 |
|
|
2021
Q4 | $8.28M | Sell |
194,900
-120,000
| -38% | -$5.04M | ﹤0.01% | 2349 |
|
|
2021
Q3 | $13.7M | Sell |
314,900
-850,000
| -73% | -$37.6M | 0.01% | 1688 |
|
|
2021
Q2 | $49.8M | Buy |
1,164,900
+489,100
| +72% | +$20.6M | 0.03% | 605 |
|
|
2021
Q1 | $26.1M | Buy |
675,800
+516,200
| +323% | +$19.5M | 0.02% | 894 |
|
|
2020
Q4 | $5.74M | Sell |
159,600
-601,700
| -79% | -$21.7M | ﹤0.01% | 2305 |
|
|
2020
Q3 | $29.1K | Buy |
761,300
+293,500
| +63% | +$11.3M | 0.04% | 574 |
|
|
2020
Q2 | $16.4M | Buy |
467,800
+442,200
| +1,727% | +$15.9M | 0.02% | 866 |
|
|
2020
Q1 | $835K | Sell |
25,600
-424,500
| -94% | -$16.6M | ﹤0.01% | 2575 |
|
|
2019
Q4 | $20.4M | Buy |
450,100
+97,700
| +28% | +$4.09M | 0.03% | 832 |
|
|
2019
Q3 | $14.3M | Buy |
+352,400
| New | +$14.9M | 0.02% | 1012 |
|
|
2019
Q2 | – | Sell |
-295,000
| Closed | -$11.3M | – | 4072 |
|
|
2019
Q1 | $11.3M | Buy |
+295,000
| New | +$11.3M | 0.02% | 1161 |
|
|
2018
Q4 | – | Sell |
-700,000
| Closed | -$26.9M | – | 3763 |
|
|
2018
Q3 | $26.9M | Sell |
700,000
-1,200,000
| -63% | -$41.9M | 0.03% | 685 |
|
|
2018
Q2 | $62.1M | Buy |
1,900,000
+1,170,000
| +160% | +$35.3M | 0.08% | 321 |
|
|
2018
Q1 | $19.9M | Buy |
730,000
+630,000
| +630% | +$17.1M | 0.03% | 879 |
|
|
2017
Q4 | $2.48M | Buy |
+100,000
| New | +$2.76M | ﹤0.01% | 2153 |
|
|
2017
Q3 | – | Sell |
-200,000
| Closed | -$5.54M | – | 3518 |
|
|
2017
Q2 | $5.54M | Buy |
+200,000
| New | +$5.31M | 0.01% | 1444 |
|
|
2016
Q4 | – | Sell |
-850,000
| Closed | -$20.2M | – | 3349 |
|
|
2016
Q3 | $20.2M | Buy |
850,000
+650,000
| +325% | +$15.5M | 0.03% | 569 |
|
|
2016
Q2 | $4.67M | Buy |
+200,000
| New | +$4.33M | 0.01% | 1306 |
|
|
2015
Q2 | – | Sell |
-11,600
| Closed | -$206K | – | 3342 |
|
|
2015
Q1 | $206K | Sell |
11,600
-296,700
| -96% | -$4.69M | ﹤0.01% | 3288 |
|
|
2014
Q4 | $4.08M | Buy |
+308,300
| New | +$3.94M | 0.01% | 1532 |
|
|
2014
Q1 | – | Sell |
-245,000
| Closed | -$2.94M | – | 3460 |
|
|
2013
Q4 | $2.94M | Buy |
+245,000
| New | +$2.89M | 0.01% | 1539 |
|
Other funds holding BSX
VCM
VPM
Millennium Management's BSX Position: Q1 2026 in Review
Millennium Management reduced its Boston Scientific (BSX) stake by 61% in Q1 2026, selling an estimated $554M and leaving 4,337,804 shares worth $241M. The position accounts for 0.1% of the portfolio, ranked #172.
Millennium Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.03B in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Millennium Management held 4,337,804 shares of Boston Scientific worth $241M as of Q1 2026.
- Millennium Management sold 6,926,986 Boston Scientific shares in Q1 2026, an estimated $554M.
- Boston Scientific made up 0.1% of Millennium Management's portfolio in Q1 2026, its #172 holding.
- Millennium Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Millennium Management's Boston Scientific position peaked at $1.03B in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.